Thanks to AI, sciences are transforming with biotech revolution - see 200 million protein DATABANK - DEEP MIND/ALPHAFOLD2
there was 50 year gap between von neumann expectations of ai method and return to generative ai and neuron networks known in his day
its probable that medicine/brugs is at interface betewwen biottech and chemistry- watch crispr gene databank wgih won jennifer doundna nobel prize fir chemistry
here's an axios upd
|By Tina Reed and Maya Goldman · Dec 11, 2023
Happy Monday, Vitals readers. Today's newsletter is 1,086 words or a 4-minute read.
|1 big thing: What's next for CRISPR
A patient suffering from complications of sickle cell disease gets an echocardiogram. Photo: Michael Williamson/The Washington Post via Getty Images.
The approval of the first CRISPR-based gene editing treatment to address the excruciating symptoms of sickle cell disease was a landmark moment for the treatment of inherited disorders.
The big picture: Casgevy, from Vertex Pharmaceuticals and CRISPR Therapeutics, is a one-time treatment in which stem cells are harvested from a patient's bone marrow, then edited to produce fetal hemoglobin, which can offset the effects of patients' defective hemoglobin.
Yes, but: The treatments aren't for everyone.
What's next: Like sickle cell, more than 6,000 rare inherited diseases are caused by a single genetic mutation — CRISPR's molecular scissors could hold potential for addressing them, USA Today noted.